0000950123-24-001863.txt : 20240213
0000950123-24-001863.hdr.sgml : 20240213
20240213160604
ACCESSION NUMBER: 0000950123-24-001863
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
EFFECTIVENESS DATE: 20240213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MPM BioImpact LLC
CENTRAL INDEX KEY: 0001687078
ORGANIZATION NAME:
IRS NUMBER: 364818254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20107
FILM NUMBER: 24625776
BUSINESS ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: BioImpact Capital LLC
DATE OF NAME CHANGE: 20210831
FORMER COMPANY:
FORMER CONFORMED NAME: MPM Oncology Impact Management LP
DATE OF NAME CHANGE: 20161007
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001687078
XXXXXXXX
12-31-2023
12-31-2023
false
MPM BIOIMPACT LLC
399 BOYLSTON STREET, SUITE 1100
BOSTON
MA
02116
13F HOLDINGS REPORT
028-20107
000309865
801-119133
N
Brendan Furey
Chief Compliance Officer
(617) 425-9203
/s/Brendan Furey
Boston
MA
02-13-2024
0
32
427428816
false
INFORMATION TABLE
2
30484.xml
INFORMATION TABLE FOR FORM 13F
Adaptimmune Therapeutics plc
Sponsored ADR
00653A107
4041058
5095912
SH
SOLE
5095912
0
0
ALX Oncology Holdings Inc.
Common
00166B105
18832262
1264759
SH
SOLE
1264759
0
0
Amicus Therapeutics Inc.
Common
03152W109
10158380
715883
SH
SOLE
715883
0
0
Avadel Pharmaceuticals PLC
Sponsored ADR
05337M104
9389602
664986
SH
SOLE
664986
0
0
Axsome Therapeutics, Inc.
Common
05464T104
7432671
93387
SH
SOLE
93387
0
0
Crinetics Pharmaceuticals Inc.
Common
22663K107
17015566
478234
SH
SOLE
478234
0
0
Cullinan Oncology, Inc.
Common
230031106
77935851
7648268
SH
SOLE
7648268
0
0
CYMABAY THERAPEUTICS INC
Common
23257D103
14436095
611181
SH
SOLE
611181
0
0
Disc Medicine Inc
Common
254604101
2888000
50000
SH
SOLE
50000
0
0
Geron Corporation
Common
374163103
22609958
10715620
SH
SOLE
10715620
0
0
Harpoon Therapeutics, Inc.
Common
41358P205
3634648
319670
SH
SOLE
319670
0
0
Inozyme Pharma Inc.
Common
45790W108
1379443
323813
SH
SOLE
323813
0
0
Insmed Incorporated
Common
457669307
16367369
528150
SH
SOLE
528150
0
0
Intellia Therapeutics, Inc.
Common
45826J105
11665413
382598
SH
SOLE
382598
0
0
Iovance Biotherapeutics Inc
Common
462260100
26743391
3289470
SH
SOLE
3289470
0
0
Karuna Therapeutics Inc
Common
48576A100
16863336
53279
SH
SOLE
53279
0
0
iTeos Therapeutics, Inc.
Common
46565G104
19118076
1745943
SH
SOLE
1745943
0
0
Madrigal Pharmaceuticals inc
Common
558868105
9465756
40910
SH
SOLE
40910
0
0
Moonlake Immunotherapeutics
Class A Ord.
61559X104
17789445
294576
SH
SOLE
294576
0
0
MORPHIC HOLDING INC
Common
61775R105
9349669
323742
SH
SOLE
323742
0
0
Olema Pharmaceuticals, Inc.
Common
68062P106
26055618
1857136
SH
SOLE
1857136
0
0
Phathom Pharmaceuticals inc
Common
71722W107
639100
70000
SH
SOLE
70000
0
0
REGENXBIO Inc.
Common
75901B107
9855950
549078
SH
SOLE
549078
0
0
Relay Therapeutics Inc.
Common
75943R102
9160507
832017
SH
SOLE
832017
0
0
Repare Therapeutics, Inc.
Common
760273102
11970898
1639849
SH
SOLE
1639849
0
0
Revolution Medicines, Inc.
Common
76155X100
7841341
273408
SH
SOLE
273408
0
0
Structure Therapeutics Inc.
Sponsored ADS
86366E106
9403169
230696
SH
SOLE
230696
0
0
Verve Therapeutics, Inc
Common
92539P101
8895992
638163
SH
SOLE
638163
0
0
VIKING THERAPEUTICS INC
Common
92686J106
6053535
325284
SH
SOLE
325284
0
0
Viridian Therapeutics Inc
Common
92790C104
2178000
100000
SH
SOLE
100000
0
0
Xeris Biopharma Holdings Inc
Common
98422E103
9040995
3847232
SH
SOLE
3847232
0
0
Werewolf Therapeutics, Inc.
Common
95075A107
9217722
2388011
SH
SOLE
2388011
0
0